首页 | 本学科首页   官方微博 | 高级检索  
检索        

美罗华联合CTNP方案治疗高龄B细胞非霍奇金淋巴瘤疗效观察
引用本文:吕明恩,蔡伟波,刘仁涛,袁幕知,沈秋丹,韩迎利.美罗华联合CTNP方案治疗高龄B细胞非霍奇金淋巴瘤疗效观察[J].中国现代医药杂志,2011,13(6):57-58.
作者姓名:吕明恩  蔡伟波  刘仁涛  袁幕知  沈秋丹  韩迎利
作者单位:南京医科大学附属苏州市立医院本部血液科,苏州,215002
摘    要:目的探讨美罗华联合CTNP方案治疗高龄非霍奇金淋巴瘤的疗效及毒副反应。方法 6例经病理证实为B细胞非霍奇金淋巴瘤高龄患者采用美罗华联合CTNP方案化疗。每3周为1个周期。观察患者治疗过程中及其后的毒副反应和疗效。结果 6例高龄患者完全缓解4例,部分缓解2例,1年总生存率83.33%。毒副反应均可耐受,主要是骨髓抑制和输液相关的不良反应。结论美罗华联合CTNP方案是治疗高龄B细胞非霍奇金淋巴瘤的一种有效方案,完全缓解率高且毒副反应小。

关 键 词:美罗华  CTNP方案  高龄  淋巴瘤

Clinical study on Rituximab combined with CTNP regiment for treatment of elderly patients with non-Hodgkin's lymphoma
Lv Ming'en,Cai Weibo,Liu Rentao,et al..Clinical study on Rituximab combined with CTNP regiment for treatment of elderly patients with non-Hodgkin's lymphoma[J].Modern Medicine Journal of China,2011,13(6):57-58.
Authors:Lv Ming'en  Cai Weibo  Liu Rentao  
Institution:Lv Ming'en,Cai Weibo,Liu Rentao,et al.Department of hematology,the Affiliated Suzhou Municipal Hospital,Nanjing Medical University,Suzhou 215002
Abstract:Objective To investigate the efficacy and safety of Rituximab combined with CTNP regiment for treatment of elderly patients with non-Hodgkin's lymphoma.Methods 6 elderly patients with B-cell Non-Hodgkin's Lymphoma were treated with Rituximab combined with CTNP regiment in our department.The efficacy and safety were evaluated during and after.Results Among 6 elderly patients with B-cell Non-Hodgkin's Lymphoma,the complete remission was observed in 4 patients and partial remission was observed in 2 patients.T...
Keywords:Rituximab CTNP regiment Lymphoma Elderly  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号